E-LIB Suche - Ergebnisse für: Bril, Vera

1

Epilepsy in neurofibromatosis type 1: Prevalence, phenotype..:

Hébert, Julien ; De Santis, Robert J. ; Daniyal, Lubna...
Epilepsy Research. 202 (2024) - p. 107336 , 2024

2

Fasted C-Peptide Distribution and Associated Clinical Facto..:

Lanctôt, Sebastien O. ; Lovblom, Leif Erik ; Lewis, Evan J.H....
Canadian Journal of Diabetes. 48 (2024) 2 - p. 89-96 , 2024

Link: https://doi.org/10.1016/..

3

Electrophysiological grading scale for polyneuropathy sever..:

Abraham, Alon ; Bril, Vera ; Hoque, Ashraful
PLOS ONE. 19 (2024) 5 - p. e0302491 , 2024

Link: https://doi.org/10.1371/..

4

Whole‐body magnetic resonance neurography in patients with ..:

Fathi, Davood ; Naraghi, Ali ; White, Lawrence M....
Muscle & Nerve. , 2024

Link: https://doi.org/10.1002/..

5

Office-based respiratory assessment in patients with genera..:

Alcantara, Monica ; Barnett-Tapia, Carolina ; Bril, Vera...
Neuromuscular Disorders. 40 (2024) - p. 1-6 , 2024

Link: https://doi.org/10.1016/..

6

Value of multi-modality small fiber assessments in a genoty..:

Alcantara, Monica ; Mannan, Shabber ; de la Cruz, James.
Medicina Clínica. , 2024

Link: https://doi.org/10.1016/..

7

Safety and Efficacy of Nipocalimab in Patients With General..:

Antozzi, Carlo ; Guptill, Jeffrey ; Bril, Vera...
Neurology. 102 (2024) 2 - p. , 2024

Link: https://doi.org/10.1212/..

8

Long-term safety, tolerability, and efficacy of efgartigimo..:

Howard Jr., James F. ; Bril, Vera ; Vu, Tuan...
Frontiers in Neurology. 14 (2024) - p. , 2024

Link: https://doi.org/10.3389/..

9

FcRn Inhibitor Therapies in Neurologic Diseases:

Alfaidi, Nouf ; Karmastaji, Salama ; Matic, Alexandria.
CNS Drugs. 38 (2024) 6 - p. 425-441 , 2024

Link: https://doi.org/10.1007/..

10

Long-term Efficacy and Safety of Symptom-driven Cyclic Roza..:

Bril, Vera ; Drużdż, Artur ; Grosskreutz, Julian...
Neurology. 100 (2023) 17_supplement_2 - p. , 2023

Link: https://doi.org/10.1212/..

11

Efgartigimod demonstrates consistent improvements in patien..:

Genge, Angela ; Bril, Vera ; Vu, Tuan...
Journal of the Neurological Sciences. 455 (2023) - p. 121088 , 2023

Link: https://doi.org/10.1016/..

12

Time to achieve a patient acceptable symptom state in myast..:

Martinez-Harms, Rodrigo ; Barnett, Carolina ; Bril, Vera
Frontiers in Neurology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

13

Randomized Double-Blind Placebo-Controlled Trial of the Cor..:

Bril, Vera ; Szczudlik, Andrzej ; Vaitkus, Antanas...
Neurology. 100 (2023) 7 - p. , 2023

Link: https://doi.org/10.1212/..

14

Effect of efgartigimod on muscle group subdomains in partic..:

Bril, Vera ; Howard Jr, James F. ; Karam, Chafic...
European Journal of Neurology. 31 (2023) 1 - p. , 2023

Link: https://doi.org/10.1111/..

15

Long-term safety, tolerability, and efficacy of efgartigimo..:

Bril, Vera ; Pasnoor, Mamatha ; Karam, Chafic...
Journal of the Neurological Sciences. 455 (2023) - p. 121089 , 2023

Link: https://doi.org/10.1016/..